Pharmacokinetic profile of caffeine in the premature newborn infant with apnea
- PMID: 430317
- DOI: 10.1016/s0022-3476(79)80047-5
Pharmacokinetic profile of caffeine in the premature newborn infant with apnea
Abstract
The pharmacokinetic profile of caffeine was studied in 32 premature newborn infants with apnea: 12 following a single intravenous dose; 3 after a single oral dose; 7 during treatment with an initial empirical (high) maintenance dose schedule; and 10 during treatment with a revised (lower) dose schedule. Mean (+/- SE) AV d, t 1/2, ke1, and clearance following a single intravenous dose were 0.916 +/- 0.070 1/kg, 102.9 +/- 17.9 hours, 0.009 +/- 0.001/hours and 8.9 +/- 1.5 ml/kg/hour, respectively. Rapid absorption was noted with plasma concentrations of 6 to 10 mg/l achieved within 30 minutes to two hours following an oral dose of 10 mg/kg. Cpss of caffeine in infants given a high empirical dose (11.2 +/- 1.5 mg/kg/day) ranged from 22.5 to 84.2 mg/l (mean = 45.3) whereas a dose schedule based on kinetic data (2.5 mg/kg/day) yielded plasma concentrations ranging from 7.4 to 19.4 mg/l (mean = 13.7). We suggest a loading dose of 10 mg/kg intravenously or orally followed by a daily maintenance dose of 2.5 mg/kg/day administered as a single dose for the treatment and prevention of neonatal apnea.
Similar articles
-
Pharmacokinetic aspects of caffeine in premature infants with apnoea.Eur J Clin Pharmacol. 1982;22(1):47-52. doi: 10.1007/BF00606424. Eur J Clin Pharmacol. 1982. PMID: 7094974
-
Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant.J Pediatr. 1979 Jun;94(6):996-8. doi: 10.1016/s0022-3476(79)80248-6. J Pediatr. 1979. PMID: 448556 No abstract available.
-
Metabolism of theophylline to caffeine in premature newborn infants.J Pediatr. 1979 Jun;94(6):988-93. doi: 10.1016/s0022-3476(79)80246-2. J Pediatr. 1979. PMID: 448554
-
Methylxanthines in apnea of prematurity.Clin Perinatol. 1979 Mar;6(1):87-108. Clin Perinatol. 1979. PMID: 383366 Review.
-
Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults.Drug Metab Rev. 1983;14(2):295-335. doi: 10.3109/03602538308991392. Drug Metab Rev. 1983. PMID: 6341027 Review. No abstract available.
Cited by
-
Caffeine in apnoeic Asian neonates: a sparse data analysis.Br J Clin Pharmacol. 2002 Jul;54(1):31-7. doi: 10.1046/j.1365-2125.2002.01589.x. Br J Clin Pharmacol. 2002. PMID: 12100222 Free PMC article.
-
Effects of photobiomodulation and caffeine treatment on acute kidney injury in a hypoxic ischemic neonatal rat model.Physiol Rep. 2023 Aug;11(15):e15773. doi: 10.14814/phy2.15773. Physiol Rep. 2023. PMID: 37549967 Free PMC article.
-
The efficacy and safety of two different doses of caffeine in respiratory function of preterm infants.Caspian J Intern Med. 2018 Winter;9(1):46-53. doi: 10.22088/cjim.9.1.46. Caspian J Intern Med. 2018. PMID: 29387319 Free PMC article.
-
Strategies for cessation of caffeine administration in preterm infants.Cochrane Database Syst Rev. 2024 Jul 24;7(7):CD015802. doi: 10.1002/14651858.CD015802.pub2. Cochrane Database Syst Rev. 2024. PMID: 39045901 Review.
-
Caffeine disposition in obesity.Br J Clin Pharmacol. 1985 Jul;20(1):61-6. doi: 10.1111/j.1365-2125.1985.tb02799.x. Br J Clin Pharmacol. 1985. PMID: 4027137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources